DiaSorin SpA (DIAS.MI)
23 May 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|79||2007||Non-Executive Chairman of the Board|
|50||2006||Chief Executive Officer, Executive Director, General Manager|
|47||2013||Non-Executive Vice Chairman of the Board|
|45||2016||Senior Corporate VP and Chief Financial Officer|
|53||Senior Corporate Vice President - Commercial Operations and Executive Director|
- BRIEF-DiaSorin launches test Liaison SHBG to diagnose androgen-related disorders
- BRIEF-DiaSorin launches Liaison androstenedione test
- BRIEF-Diasorin Q1 net profit rises to EUR 32.0 million
- BRIEF-Diasorin receives authorization for distribution of Zika IgM test in Europe
- BRIEF-DiaSorin receives FDA emergency use authorization for Zika IgM test